Literature DB >> 25276275

Penetration of ((14)C)-Efinaconazole Topical Solution, 10%, Does Not Appear to be Influenced by Nail Polish.

Joshua A Zeichner1, Linda Stein Gold1, Andrew Korotzer1.   

Abstract

Onychomycosis is a common nail disorder with significant medical impacts and aesthetic consequences. Patients seek treatment for several reasons, including the unsightliness of the nail(s). Even with successful management, it takes months for the diseased nail to appear cosmetically normal. Patients commonly apply nail polish to mask the appearance of the dystrophic nail, though it is contraindicated with the currently available topical lacquers for onychomycosis. The authors' nonclinical study using a cadaver nail model showed that penetration of efinaconazole topical solution, 10%, a new antifungal being developed for the treatment of mild-to-moderate toenail onychomycosis, was not influenced by application of nail polish. Polishes showed an increase in surface tackiness with repeated efinaconazole topical solution, 10% application. The medical and aesthetic significance of the authors' findings have yet to be assessed clinically.

Entities:  

Year:  2014        PMID: 25276275      PMCID: PMC4174918     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  12 in total

1.  Quality of life issues for patients with fungal nail infections.

Authors:  L Drake
Journal:  AIDS Patient Care       Date:  1995-12

2.  Factors influencing coexistence of toenail onychomycosis with tinea pedis and other dermatomycoses: a survey of 2761 patients.

Authors:  Jacek C Szepietowski; Adam Reich; Emilia Garlowska; Marzena Kulig; Eugeniusz Baran
Journal:  Arch Dermatol       Date:  2006-10

3.  Effect of onychomycosis on quality of life.

Authors:  L A Drake; R K Scher; E B Smith; G A Faich; S L Smith; J J Hong; M J Stiller
Journal:  J Am Acad Dermatol       Date:  1998-05       Impact factor: 11.527

4.  Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter canadian survey of 15,000 patients.

Authors:  A K Gupta; H C Jain; C W Lynde; P Macdonald; E A Cooper; R C Summerbell
Journal:  J Am Acad Dermatol       Date:  2000-08       Impact factor: 11.527

5.  Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis-specific questionnaire.

Authors:  J C Szepietowski; A Reich; P Pacan; E Garlowska; E Baran
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-04       Impact factor: 6.166

6.  The effect of toenail onychomycosis on patient quality of life.

Authors:  B E Elewski
Journal:  Int J Dermatol       Date:  1997-10       Impact factor: 2.736

Review 7.  Common dermatophyte infections. A simple diagnostic test and current management.

Authors:  J T Crissey
Journal:  Postgrad Med       Date:  1998-02       Impact factor: 3.840

8.  Onychomycosis.

Authors:  C Seebacher; J Brasch; D Abeck; O Cornely; I Effendy; G Ginter-Hanselmayer; N Haake; G Hamm; U-Ch Hipler; H Hof; H C Korting; P Mayser; M Ruhnke; K-H Schlacke; H-J Tietz
Journal:  Mycoses       Date:  2007-07       Impact factor: 4.377

9.  Stigmatisation in onychomycosis patients: a population-based study.

Authors:  Jacek C Szepietowski; Adam Reich
Journal:  Mycoses       Date:  2008-09-12       Impact factor: 4.377

10.  Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.

Authors:  Boni E Elewski; Phoebe Rich; Richard Pollak; David M Pariser; Shinichi Watanabe; Hisato Senda; Chikara Ieda; Kathleen Smith; Radhakrishnan Pillai; Tage Ramakrishna; Jason T Olin
Journal:  J Am Acad Dermatol       Date:  2012-11-20       Impact factor: 11.527

View more
  9 in total

1.  Effect of intratympanic application of efinaconazole 10 % solution in the guinea pig.

Authors:  Kazuya Arakawa; Kazuhiro Nomura; Hidetoshi Oshima; Yohei Honkura; Ryoukichi Ikeda; Hiroshi Hidaka; Tetsuaki Kawase; Yukio Katori
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-30       Impact factor: 2.503

2.  Ciclopirox Hydroxypropyl Chitosan (CPX-HPCH) Nail Lacquer and Breathable Cosmetic Nail Polish: In Vitro Evaluation of Drug Transungual Permeation Following the Combined Application.

Authors:  Daniela Monti; Silvia Tampucci; Valentina Paganini; Susi Burgalassi; Patrizia Chetoni; Jordi Galván; Francesco Celandroni; Emilia Ghelardi
Journal:  Life (Basel)       Date:  2022-05-27

Review 3.  Application of Nail Polish During Topical Management of Onychomycosis: Are Data Available to Guide the Clinician About What to Tell Their Patients?

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2016-08-01

Review 4.  Efinaconazole in the treatment of onychomycosis.

Authors:  Shari R Lipner; Richard K Scher
Journal:  Infect Drug Resist       Date:  2015-06-01       Impact factor: 4.003

Review 5.  Patient considerations in the management of toe onychomycosis - role of efinaconazole.

Authors:  Charlotte E LaSenna; Antonella Tosti
Journal:  Patient Prefer Adherence       Date:  2015-06-30       Impact factor: 2.711

Review 6.  Onychomycosis: An Updated Review.

Authors:  Alexander K C Leung; Joseph M Lam; Kin F Leong; Kam L Hon; Benjamin Barankin; Amy A M Leung; Alex H C Wong
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2020

Review 7.  Updated Perspectives on the Diagnosis and Management of Onychomycosis.

Authors:  Julianne M Falotico; Shari R Lipner
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-15

8.  Single-Center, Prospective, Blinded Study Comparing the Efficacy and Compatibility of Efinaconazole 10% Solution in Treating Onychomycosis with and without Concurrent Nail Polish Use.

Authors:  Theresa N Canavan; Stephanie L Bevans; Wendy C Cantrell; Casey Wang; Boni E Elewski
Journal:  Skin Appendage Disord       Date:  2018-04-25

Review 9.  The Dermatologist's Approach to Onychomycosis.

Authors:  Jenna N Queller; Neal Bhatia
Journal:  J Fungi (Basel)       Date:  2015-08-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.